MedTrace Logo

Comfort and Antimicrobial Efficacy of Chlorhexidine vs Betadine for Intravitreal Injections

NCT03571100 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-06-27

No results posted yet for this study

Summary

The purpose of this prospective interventional study is to compare patient experience, ocular surface irritation, and bacterial colony counts and microbial spectrum between povidine iodine and aqueous chlorhexidine as ocular surface antiseptic prior to intravitreal injection

Conditions

  • Age-related Macular Degeneration
  • Diabetic Vascular Diseases
  • Proliferative Retinopathy
  • Retina Vein Occlusion

Interventions

DRUG

Chlorhexidine

Chlorhexidine administration prior to intravitreal injection (compared to gold standard povidine-iodine)

DRUG

Povidine-Iodine

Povidine iodine administration prior to intravitreal injection (compared to chlorhexidine)

Sponsors & Collaborators

  • MidAtlantic Retina

    lead OTHER

Principal Investigators

  • Sunir Garg, MD · MidAtlantic Retina

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-07
Primary Completion
2019-05-06
Completion
2019-05-06
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03571100 on ClinicalTrials.gov